VXRT — Vaxart Cashflow Statement
0.000.00%
Last trade - 00:00- $131.37m
- $98.08m
- $7.38m
Annual cashflow statement for Vaxart, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.6 | -32.2 | -70.5 | -108 | -82.5 |
| Depreciation | |||||
| Non-Cash Items | 0.677 | 2.96 | 8.55 | 13.9 | 12.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.28 | 2.81 | -2.12 | -6.7 | -8.85 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -13.1 | -23.8 | -59.8 | -94.8 | -70.5 |
| Capital Expenditures | -0.85 | -1.22 | -5.16 | -9.6 | -1.87 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.003 | -43.9 | -10.8 | 45.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.85 | -1.22 | -49.1 | -20.4 | 44 |
| Financing Cash Flow Items | — | 0.652 | 0 | — | -0.366 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16 | 138 | 126 | 17.5 | 15.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.02 | 113 | 16.9 | -97.7 | -11.3 |